The Department of Critical Care Medicine is pleased to announce the hire of Sherry Hsiang-Yi Chou as a Visiting Associate Professor. Chou, who holds an MD from McGill University (Montreal) and an M.MSc from Harvard Medical School, holds secondary appointments in the Departments of Neurology and Neurosurgery.
Dr. Chou is a board-certified neurologist with subspecialty training and board certifications in critical care and vascular neurology. A member of the Board of Directors for the Neurocritical Care Society, Dr. Chou also carries the title of Fellow of Neurocritical Care Society (FNCS). She is a member of The Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) and the Safar Center, here at the University of Pittsburgh School of Medicine. Dr. Chou is also a visiting scientist at The Neuroprotection Research Laboratory, Department of Radiology, Massachusetts General Hospital, and a visiting scientist in the Department of Neurology, Brigham and Women’s Hospital.
Dr. Chou’s clinical practice focuses on patients with critical injuries to their central nervous system. Her research focuses on the use of human molecular biomarkers to probe mechanisms and predict outcomes in acute brain injury conditions such as subarachnoid hemorrhage (SAH) and hypoxic ischemic brain injury from cardiac arrest. She is funded with a K23 award, and the goals of this work include: 1) to better define human pathophysiology of SAH-related vasospasm and brain injury using molecular biomarkers, 2) to develop novel diagnostic molecular biomarkers in SAH, and 3) to define novel molecular therapeutic targets for secondary brain injury in SAH. Dr. Chou also participates as co-investigator in multicenter clinical trials in acute brain injuries including ischemic stroke, intracerebral hemorrhage, SAH, and traumatic brain injury.
Dr. Chou has published over 50 papers, reviews and book chapters, and has received numerous honors for her research and scholarly work contributions. She has also shared her clinical and translational research advances in critical care neurology at grand rounds at Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, Boston Medical Center, New England Medical Center/Tufts University, University of Massachusetts Medical Center, and Cedar Sinai Medical Center as well as at in local, national, and international conferences. Dr. Chou has also been invited as peer reviewer and moderator at national meetings for the Neurocritical Care Society, the Society of Critical Care Medicine, the American Academy of Neurology, and at the International Stroke Conferences. She has taught CME courses in neurocritical care and vascular neurology at Harvard Medical School and nationally, and has been an active reviewer for publications in the field of critical care and vascular neurology for journals such as Stroke, Critical Care Medicine, Neurocritical Care, and Intensive Care Medicine.
Welcome, Dr. Chou!